Obseva: résultats prometteurs pour le traitement linzagolix
28.09.2018
Share this article
Final results of ObsEva SA Phase 2b EDELWEISS trial of Linzagolix show sustained efficacy and Bone Mineral Density safety, for the treatment of endometriosis-associated pain